Physician profile
Mark Bender
NPI 1659603090
$12,237.40
in general payments reported to CMS, 2019-2025
16 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,538 · 2022: $4,448 · 2023: $220 · 2024: $751 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075 · Travel and Lodging: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,075.31 |
| Travel and Lodging | $175.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,017.53 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Medtronic, INC. | $962.88 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $411.07 | 2023-2025 | Proclaim, Eterna |
| Pacira Pharmaceuticals Incorporated | $229.93 | 2025 | Iovera |
| Saluda Medical Americas, INC. | $159.34 | 2025 | Evoke |
| Nevro Corp. | $109.08 | 2022-2023 | Senza |
| Si-Bone, INC. | $74.12 | 2024 | |
| Stimwave Technologies Incorporated | $69.00 | 2021 | |
| Alevio, LLC | $67.29 | 2023 | Sicure Sacroiliac Joint Fusion System |
| Spinal Simplicity, LLC | $30.32 | 2024 | Ha Minuteman G3-R |
| Abbvie INC. | $28.41 | 2025 | |
| Merz Pharmaceuticals, LLC | $18.76 | 2025 | Xeomin |
| Averitas Pharma INC. | $17.66 | 2023 | Qutenza |
| Stryker Corporation | $14.21 | 2021 | |
| Foundation Fusion Solutions, LLC | $14.06 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13.74 | 2025 | Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.